// App-Quantinova.ai

[THU0410] : THE EFFICACY OF RITUXIMAB FOR REFRACTORY THROMBOTIC MICROANGIOPATHY (TMA) ASSOCIATED WITH CONNECTIVE TISSUE DISEASES REGARDLESS OF ADAMTS-13 ACTIVITY LEVELS

Researchers

Presenter

  • Y. Takeuchi

Principal Investigators

  • T. Kameda

  • M. Izumikawa

  • S. Nakashima

  • H. Shimada

  • H. Ozaki

  • R. Wakiya

  • H. Dobashi

Medical Centers

  • Department of Internal Medicine, Division of Hematology, Rheumatology, and Respiratory Medicine, Faculty of Medicine, Kagawa University, Kagawa, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Thrombotic thrombocytopenic purpura

  • Lupus

  • Thrombotic microangiopathy

  • Malignant hypertension

  • Sjogren's syndrome

  • Thrombocytopenia

  • Hypertension

  • Venous thrombosis

  • Anemia

Biomarkers

  • von Willebrand factor

Drug/Treatment

  • Rituximab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved